|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�������� |
|
���Ժ����� |
| ��������������� | |
|
�Ӣ���� |
|
��������У |
| PubMed | |
|
Article by |
|
Article by |
���Ժ�����������������Ӱ�����ؼ��Բ�
�Ӣ����, ��������У
���ľ�ҽ��ѧ����ҽԺƤ����
���������ǽ��귢չ������һ���µ��������Ƽ���,���ǽ���ԭ�����¡���ض�������,ʹ��������ں��ﲢ�յ����������Ӧ��ϸ������Һ���߷�Ӧ��������������Ĺؼ���ѡ����ʵ�Ŀ�Ļ���ʹ�ø�Ч�����塣���������������Ƶ�Ч���ܶ������ص�Ӱ��,�ܶ��о�ͨ��̽�ֲ�ͬ���Ż������������������������,�ڶ��Ժ�������ʵ���������Ѿ�ȡ�������õ�Ч��,���Ҿ��нϺõ�Ӧ��ǰ����
[2] Reimann J, Kaufmann SH. Altemative antigen processing pathways in anti-infective immunity. Curr Opin Immunol, 1997,9(4):462-469.
[3] Stenger S, Modlin RL. Cytoxic T cell responses to intracellular pathogens.Curr Opin Immunol, 1998,10(4):471-477.
[4] Reis e Sousa C, Sher A, Kaye P. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr Opin Immunol,1999, 11(4):392-399.
[5] Doe B, Selby M, Barnett S, et al. Introduction of cytotoxic T lymphucytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow derived cells. Proc Natl Acad Sci USA, 1996, 93(16):8578-8583.
[6] Park JH, Kim CJ, Lee JH, et gl. Effective immunotherapy of cancer by DNA vaccination. Mol Cells, 1999,9(4):384-391.
[7] Ribas A, Butterfield LH, McBride WH, et al. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirustransduced murine dendritic cells. Cancer Res, 1997,57(14):2865-2869.
[8] Zhou WZ, Kaneda Y, Huang S, et al. Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine. Gene Ther, 1999, 6(10):1768-1773.
[9] Bronte V, Apolloni E, Ronca R, et al. Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.Cancer Res, 2000,60(2):253-258.
[10] Krieg AM, Yi Ak, Matson S, et al. CpG, motifs in bacterial DNA trigger direct B-cell activation. Nature, 1995,374(6522):546-549.
[11] Janik JE, Miller LL, Kopp WC, et al. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients. Clin Immunol,1999, 93(3):209-221.
[12] Tuting T, Gambotto A, DeLco A,et al. Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice. Cancer Gene Ther,1999,6(1):73-80.
[13] Nawrath M, Heinrich J, Strack B, et al. A DNA vaccine against malignant melanoma coexpressing antigen and cytokine. Adv Exp Med Biol,1998,451:305-310.
[14] Xiang R, Lode HN, Chao TH, et al. An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci USA, 2000, 97(10):5492-5497.
[15] Hawkins WG, Gold JS, Dyall R, et al. Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity. Surgery,2000, 128(2):273-280.
[16] Steitz J, Bruck J, Steinbrink K, et al. Genetic immunization of mice with human tyrosinase-related protein 2:implications for the immunotherapy of melanoma. Int J Cancer, 2000,86(1):89-94.
[17] Novakovic S, Ihan A, Jezersek B. Effectivenness of a simply designed tumor vaccine in prevention of malignant melanoma development. Jpn J Cancer Res, 1999,90(10):1130-1138.